Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

20/20's BioCheck(R) Kit for Screening Suspicious Powders Receives SAFETY Act Designation from DHS.


ROCKVILLE, Md. -- The BioCheck[R] Powdered Screening Test Kit, a product of 20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc. has earned designation as a Qualified Anti-Terrorism Technology under the U.S. Department of Homeland Security Noun 1. Department of Homeland Security - the federal department that administers all matters relating to homeland security
Homeland Security

executive department - a federal department in the executive branch of the government of the United States
 (DHS DHS Department of Homeland Security (USA)
DHS Department of Human Services
DHS Department of Health Services
DHS Demographic and Health Surveys
DHS Dirhams (Morocco national currency) 
)'s SAFETY Act .

The SAFETY (Support Anti-terrorism by Fostering Effective Technologies) Act encourages the development and rapid deployment of anti-terrorism technologies by giving buyers and sellers of qualified technologies liability protection from lawsuits. This effectively protects 20/20, as well as its customers and resellers, from the consequences of litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 arising from the use of the designated product in a terrorist incident.

"This designation is an important milestone for our company and our BioCheck[R] customers," said Jerry Troy, Vice President of 20/20 BioResponse. "In addition to validating the safety and efficacy of the product, based on an extensive DHS review that spanned several months, it helps guard our customers and distributors against lawsuits that could follow an act of bioterrorism."

The BioCheck[R] Kit (www.BioCheckInfo.com) is a market leader in the screening of suspicious powders and is used by more than 500 first responder first responder First response personnel Emergency medicine A person employed in the public sector–EMT, fire fighter, police, volunteer EMS–whose duties include provision of immediate medical care in the event of an emergency; FRs have basic emergency  organizations worldwide. Users include fire departments in major jurisdictions and more than a dozen U.S. federal agencies. The kit provides a rapid screen to rule out the presence of multiple bioterrorism agents (e.g. anthrax anthrax (ăn`thrăks), acute infectious disease of animals that can be secondarily transmitted to humans. It is caused by a bacterium (Bacillus anthracis , ricin ricin /ri·cin/ (ri´sin) a phytotoxin in the seeds of the castor oil plant (Ricinus communis), used in the synthesis of immunotoxins.

ri·cin
n.
, botulism botulism (bŏch`əlĭz'əm), acute poisoning resulting from ingestion of food containing toxins produced by the bacillus Clostridium botulinum.  toxin) in suspicious powders. The product requires no instrumentation and helps first responders determine in five minutes or less whether testing for one or more specific pathogens or toxins is warranted. The novel technology in the BioCheck Kit is protected by two U.S. patents.

20/20 BioResponse (www.2020BioResponse.com) develops biotechnology solutions for first responders. It is a unit of 20/20 GeneSystems, Inc. (www.2020gene.com) that focuses on innovative diagnostics products for cancer and other medical applications. The company is privately held and headquartered in Rockville, Maryland.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 17, 2007
Words:317
Previous Article:Fitch Rates CPORTS 2006-1 Class B-E Notes.
Next Article:Boenning & Scattergood Announces Investment Opinion on ISIS Pharmaceuticals, Inc.
Topics:



Related Articles
ARE YOU BEING WELL-SERVED? IN L.A., IT'S A MIXED BAG.
'SHAOLIN WARRIORS'.
DAU faculty judge intercollgiate Ethics Competition.
Department of Defense News Release (July 5, 2007): DoD announces "wearable power" prize competition.
Late goals help Sisters slip past Spartans.
Take the wheel: the Pension Protection Act doesn't mean you can sit back and relax.
To give and receive: how to pass on 401(k) assets and manage an inheritance.
Hello from New York City (4) - Staten Island and a Random Act of Violence
A Small Sense Behind the UK Constitutional Reform Act 2005

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles